186 related articles for article (PubMed ID: 24246847)
21. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation.
Chiba T; Marusawa H; Ushijima T
Gastroenterology; 2012 Sep; 143(3):550-563. PubMed ID: 22796521
[TBL] [Abstract][Full Text] [Related]
22. [NKT cells in the liver environment interact with Wnt/β-catenin and promote the emergence of liver carcinoma].
Anson M; Viguier M; Perret C; Couty JP
Med Sci (Paris); 2012 May; 28(5):473-5. PubMed ID: 22642999
[No Abstract] [Full Text] [Related]
23. Regression of an inflammatory myofibroblastic tumor of the porta-hepatis with steroid drugs.
Khmekhem R; Ben Dhaou M; Ghorbel S; Mattoussi N; Ben Becheur S; Chaouachi B
Tunis Med; 2012 Jun; 90(6):492-3. PubMed ID: 22693097
[No Abstract] [Full Text] [Related]
24. The role of chronic inflammation in the development of gastrointestinal cancers: reviewing cancer prevention with natural anti-inflammatory intervention.
Lee HJ; Park JM; Han YM; Gil HK; Kim J; Chang JY; Jeong M; Go EJ; Hahm KB
Expert Rev Gastroenterol Hepatol; 2016; 10(1):129-39. PubMed ID: 26524133
[TBL] [Abstract][Full Text] [Related]
25. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation.
Servais C; Erez N
J Pathol; 2013 Jan; 229(2):198-207. PubMed ID: 22996812
[TBL] [Abstract][Full Text] [Related]
26. The role of cytokines in hepatocellular carcinoma.
Budhu A; Wang XW
J Leukoc Biol; 2006 Dec; 80(6):1197-213. PubMed ID: 16946019
[TBL] [Abstract][Full Text] [Related]
27. Chronic inflammation and cancer: potential role of Bcl-2 gene family members as regulators of cellular antioxidant status.
Frommel TO; Zarling EJ
Med Hypotheses; 1999 Jan; 52(1):27-30. PubMed ID: 10342667
[TBL] [Abstract][Full Text] [Related]
28. Role of prostanoids in gastrointestinal cancer.
Wang D; DuBois RN
J Clin Invest; 2018 Jul; 128(7):2732-2742. PubMed ID: 29733297
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor and anti-tumor necrosis factor therapies.
Keystone EC; Ware CF
J Rheumatol Suppl; 2010 May; 85():27-39. PubMed ID: 20436163
[TBL] [Abstract][Full Text] [Related]
30. Chronic inflammation is an important risk factor for the development of gastrointestinal cancer. Preface.
Dítě P
Dig Dis; 2010; 28(4-5):573. PubMed ID: 21088403
[No Abstract] [Full Text] [Related]
31. New insights into mechanisms of gastrointestinal inflammation and cancer.
Ward SG; Mrsny R
Curr Opin Pharmacol; 2009 Dec; 9(6):677-9. PubMed ID: 19857997
[No Abstract] [Full Text] [Related]
32. Contradictory functions of NF-kappaB in liver physiology and cancer.
Vainer GW; Pikarsky E; Ben-Neriah Y
Cancer Lett; 2008 Aug; 267(2):182-8. PubMed ID: 18479806
[TBL] [Abstract][Full Text] [Related]
33. Inflammation in sporadic colorectal cancer.
Moossavi S; Bishehsari F
Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
[TBL] [Abstract][Full Text] [Related]
34. Inflammation and cancer stem cells.
Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W
Cancer Lett; 2014 Apr; 345(2):271-8. PubMed ID: 23941828
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory Treatment for Seemingly Non-inflammatory Disorders. Editorial.
Maru Y
Endocr Metab Immune Disord Drug Targets; 2015; 15(2):82. PubMed ID: 26004772
[No Abstract] [Full Text] [Related]
36. Chronic inflammatory IFN-γ signaling suppresses hepatocarcinogenesis in mice by sensitizing hepatocytes for apoptosis.
Lüth S; Schrader J; Zander S; Carambia A; Buchkremer J; Huber S; Reifenberg K; Yamamura K; Schirmacher P; Lohse AW; Herkel J
Cancer Res; 2011 Jun; 71(11):3763-71. PubMed ID: 21512142
[TBL] [Abstract][Full Text] [Related]
37. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising.
Whiteman M; Winyard PG
Expert Rev Clin Pharmacol; 2011 Jan; 4(1):13-32. PubMed ID: 22115346
[TBL] [Abstract][Full Text] [Related]
38. Chronic inflammation and the development of malignancy in the GI tract.
Fichtner-Feigl S; Kesselring R; Strober W
Trends Immunol; 2015 Aug; 36(8):451-9. PubMed ID: 26194796
[TBL] [Abstract][Full Text] [Related]
39. The role of the mediators of inflammation in cancer development.
Fernandes JV; Cobucci RN; Jatobá CA; Fernandes TA; de Azevedo JW; de Araújo JM
Pathol Oncol Res; 2015 Jul; 21(3):527-34. PubMed ID: 25740073
[TBL] [Abstract][Full Text] [Related]
40. Editorial: update on inflammatory targets modulating atherogenesis.
Carbone F; Mach F; Montecucco F
Curr Drug Targets; 2015; 16(4):282-3. PubMed ID: 25859799
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
